menu
    • menu

    Company profile for NANOTHERAPEUTICS INC

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nanotherapeutics is an integrated biopharmaceutical company with a focus on development and manufacturing. The Company has expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. The Company's proprietary platform technologies can be used with all drug types, ranging from small molecules to proteins and vaccines. Nanotherapeutics ha...
    Nanotherapeutics is an integrated biopharmaceutical company with a focus on development and manufacturing. The Company has expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. The Company's proprietary platform technologies can be used with all drug types, ranging from small molecules to proteins and vaccines. Nanotherapeutics has significant expertise in product formulation, scale-up and cGMP manufacturing, utilizing established as well as our proprietary techniques: NanoQUAD®, NanoDRY®, and GelSite®/GelVac™. Our specialized technologies, proprietary processing techniques and know-how set us apart from most other biopharmaceutical companies. Key pharmaceutical advantages of our technologies include: Broad applicability - Our delivery options are applicable to a diverse group of drug molecules - proteins, peptides and other poorly absorbed compounds. Versatility of formulation - We have created various types of injectable, inhaled/nasal, topical, and oral formulations using our particle-based delivery expertise. Stabilization - We have demonstrated more than three years of room temperature stability with different formulations - including vaccines - without loss of activity or dispersability. Ease of Manufacture - Scale-up to commercial quantities of production is readily obtainable at cost-effective levels.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NANOTHERAPEUTICS INCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    13859 Progress Blvd
    Telephone
    Telephone
    386-462-9663
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cyrus Poonawalla Group acquires Nanotherapeutics' human vaccine manufacturing
    Cyrus Poonawalla Group acquires Nanotherapeutics' human vaccine manufacturing

    03 May 2017

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=101736&sid=2

    PHARMABIZ
    03 May 2017
    Share Share
    Takeda expands vaccine platform rights with Nanotherapeutics agreement
    Takeda expands vaccine platform rights with Nanotherapeutics agreement

    28 Aug 2015

    // Eric Sagonowsky FIERCE VACCINES

    http://www.fiercevaccines.com/story/takeda-expands-vaccine-platform-rights-nanotherapeutics-agreement/2015-08-27

    Eric Sagonowsky FIERCE VACCINES
    28 Aug 2015
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    ABOUT THIS PAGE

    Contact NANOTHERAPEUTICS INC and get a quotation

    NANOTHERAPEUTICS INC is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find 3-aminopyridine-2-carboxaldehyde thiosemicarbazone bulk with DMF offered by NANOTHERAPEUTICS INC

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search